Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems all connected to Pfizer news. Notice how that stock continues to underperform? I see this being a short term event and we go up soon.
Until you said that...
Absolutely! One month out from data being unblinded off we complete enrollment this week as anticipated. That means, if data is continuing to be in-line with the early data we saw, that this could very well see EUA immediately after, then followed by FDA approval. Very possible. Do we know of any other therapeutic treatments for this population that are at this point? Others have stopped or failed recently, so my understanding is that we may be the only one. Is that correct?
expected to remain stable at standard refrigerator temperatures of 2° to 8°C (36° to 46°F) for 30 days. That is great for a lot of reasons. Still doesn’t solve for those who are already sick. Hoping we can get data finished , EUA in place and an FDA approval soon
.53 now but still great to see
Bid ask is at .4510/.6690....looks like a promising day ahead hopefully
Swiss is going UP!!
Agree. Still, might expect a drop based on the way it behaved with the Pfizer news. Hopefully we get news on enrollment completion this week
Modern a states their vaccine is 94.5% effective at prevention apparently....
Additionally, the are not owners of any investment. They have only “control” or “minority” investments. They are a portfolio based investment firm, with venture capital allotment, and only fund for growth opportunities. So, buying companies is not their goal.
I think GEM stands to make much more money with a pps increase into the dollars than they would if they owned the company. Reason would be that they have to assume corporate taxation in addition to registration costs, legal costs, etc. so why would they buy the company? They make more by just sitting and waiting
.3440/.3680 already... looking good
Exactly. The drop already occurred a few days ago. This goes up today
This is an interesting point to consider
This is the best PR they’ve done in weeks!! Finally they have someone in that PR job who gets it! Now we also know the big drop was GEM diluting shares which is also great transparency on their part to disclose. I am not fond of the fact there is still 80 million left to dilute and that the o/S is now above 3billion though....
Will be an interesting next few weeks here. Monday morning EUA approval news would absolutely blow this up
“RLF-100 is believed to be the first COVID-19 therapeutic to demonstrate the ability to block replication of the SARS-CoV-2 virus in human lung cells and monocytes, while also preventing synthesis of cytokines in the lung.”......enough said
This trading pattern is new...I wonder if MM see the exchange change as a threat and are trying to create as much volatility as possible....
Such low volume for this to be acting like this...so odd
I agree a BIG WTF?!?
Break that .36 already! Then we can hunt for .40
No because it is not from the blinded trial, and the NIH is asking for data and information to be disclosed so they can make progress
Not so sure “money midnight” is going to get us the exposure we want...at least it is something though
Hopefully they get something to happen
More BS today. Look forward to EUA announcement
Swiss dropping again. Ugh wtf??
You clearly do not understand the virus or what Pfizer has produced compared to what this THERAPEUTIC provides...
Right now would be an ideal time to release something that catches the market off guard and steals some huge momentum
Who are you? Please read the science here before spouting off that nonsense. We are one of the few who will never face that level of scrutiny by the SEC or the FDA. We have clinical trials in phase 2/3, we have a solid DMC with 7 reviewers who have already approved continuation of our trials, we have no concerns on safety of efficacy....please stop what you are doing and go elsewhere
That is correct. An often overlooked variable with investors in this space. Although treatments could address multiple strains, what we do not yet know is whether what Pfizer has is effectively able to do that.
Same on TD Ameritrade
Again, keep your drama at home. The science here is absolutely on the mark, with p-values at <.0001 this is a high level of statistical significance when compared to any other competitor. Hence why we already have compassionate use from FDA, why EUA is likely, and also why the FDA is also likely aware
My lord you are so dramatic all the time
Pfizer has already dropped and is only up $3/share....again, if it was as impactful as the high-level data suggested then why wouldn’t this jump much higher. We will rebuild from this base. Our news IS coming; our data and science ARE good. Patience
Haha, well that certainly doesn’t help matters in the current context
Look, this is all overreacting by investors. Look at Pfizer. If this was world changing and something that was a clear winner, would they not be up by more than 14%??? Especially at the level of affordability and price they are at? There is a narrative still being written on COVID treatments, and what they offer is only a part of that.
Look, all companies are taking a hit. You are being way too dramatic. Even Abbott, for example, is down 6% pre-market...they are one company that has products and tests meant to compliment something like this. So to state with such confidence the way you do is a little misleading. We are a small player here and need to keep that in mind at the moment
Exactly. Science here is very solid. So a long term approach is going to be needed for anyone looking to make money unless we get the EUA and FDA approval soon